Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary

Persons with inflammatory bowel disease (IBD) make up more than 0.75% of the Canadian population in 2021. Early in the COVID-19 pandemic, individuals with IBD, particularly those on immunosuppressive therapies, were concerned that their health status may place them at higher risk of contracting COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellen Kuenzig, M, Windsor, Joseph W, Barrett, Lisa, Bernstein, Charles N, Bitton, Alain, Carroll, Matthew W, Chauhan, Usha, Coward, Stephanie, Fowler, Sharyle, Ghia, Jean-Eric, Geist, Rose, Gibson, Deanna L, Graff, Lesley A, Griffiths, Anne M, Guoxian Huang, James, Jones, Jennifer L, Khanna, Reena, Lakatos, Peter L, Lee, Kate, Mack, David R, Marshall, John K, Mukhtar, Mariam S, Murthy, Sanjay K, Nguyen, Geoffrey C, Panaccione, Remo, Seow, Cynthia H, Singh, Harminder, Tandon, Parul, Targownik, Laura E, Zelinsky, Sandra, Benchimol, Eric I, Kaplan, Gilaad G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570424/
https://www.ncbi.nlm.nih.gov/pubmed/34755033
http://dx.doi.org/10.1093/jcag/gwab027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570424/
https://www.ncbi.nlm.nih.gov/pubmed/34755033
http://dx.doi.org/10.1093/jcag/gwab027

Ejemplares similares